Skip to main content
Fig. 1 | Allergy, Asthma & Clinical Immunology

Fig. 1

From: MicroRNA-29 mediates anti-inflammatory effects and alleviation of allergic responses and symptoms in mice with allergic rhinitis

Fig. 1

Allergic rhinitis (AR) suppresses the expression of miRNA-29 (miR-29) in the nasal mucosa. a Expression of miR-29 in the nasal mucosa of human AR patients. Nasal mucosa samples were collected from nine pairs of age-matched AR patients and healthy controls. ***, P < 0.001 vs. Con by t-test. b Expression of miR-29 in the nasal mucosa of OVA(ovalbumin)-induce AR mice. The data are presented as mean ± SEM, n = 9 for each group. c Schema showing the design of the animal experiments. ***, P < 0.001 vs. Con

Back to article page